Back of napkin calcs.
$150k in 2 weeks, $300k a month, $1.2m in 4 months of winter. Double distribution numbers and we have $2.4m, assuming similar sales numbers.
This sort of revenue extends cash flow, and along with potential success of FebriDx could lead to cash flow positive in 6 months or so.
This is a company making turnaround. From $1.40 to 1c, back to a speccy $1+ stock.
Back of napkin calcs. $150k in 2 weeks, $300k a month, $1.2m in...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
2.7¢ |
Change
-0.002(6.90%) |
Mkt cap ! $20.21M | |||
| Open | High | Low | Value | Volume |
| 2.8¢ | 2.8¢ | 2.7¢ | $37.38K | 1.357M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 337500 | 2.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.7¢ | 942945 | 1 |
View Market Depth
| Last trade - 15.55pm 23/06/2025 (20 minute delay) ? |
| LDX (ASX) Chart |